The Trial Problem the Bill AddressesAntibiotic trials fail on logistics in ways that trials for chronic disease drugs do not. The official title refers to the Antibiotic Resistance Leadership Group, while sponsors' press materials and news coverage describe an Antimicrobial Resistance Leadership Group. Require the director of the National Institute of Allergy and Infectious Diseases to award a competitive grant supporting a clinical research network on antibiotic resistance. Why are antibiotic trials so hard to run? It targets clinical trial infrastructure rather than the market conditions that make antibiotic development commercially difficult.